110 related articles for article (PubMed ID: 35645111)
41. Dosimetric comparison of three intensity-modulated radiation therapies for left breast cancer after breast-conserving surgery.
Zhang HW; Hu B; Xie C; Wang YL
J Appl Clin Med Phys; 2018 May; 19(3):79-86. PubMed ID: 29524290
[TBL] [Abstract][Full Text] [Related]
42. Anterior myocardial territory may replace the heart as organ at risk in intensity-modulated radiotherapy for left-sided breast cancer.
Tan W; Liu D; Xue C; Xu J; Li B; Chen Z; Hu D; Wang X
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1689-97. PubMed ID: 21621342
[TBL] [Abstract][Full Text] [Related]
43. Comparison of volumetric-modulated arc therapy and intensity-modulated radiation therapy prostate cancer plans accounting for cold spots.
Nguyen TTT; Arimura H; Asamura R; Hirose TA; Ohga S; Fukunaga JI
Radiol Phys Technol; 2019 Jun; 12(2):137-148. PubMed ID: 30805779
[TBL] [Abstract][Full Text] [Related]
44. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
[TBL] [Abstract][Full Text] [Related]
45. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
[TBL] [Abstract][Full Text] [Related]
46. Impact of database quality in knowledge-based treatment planning for prostate cancer.
Wall PDH; Carver RL; Fontenot JD
Pract Radiat Oncol; 2018; 8(6):437-444. PubMed ID: 29730280
[TBL] [Abstract][Full Text] [Related]
47. Dosimetric comparison between helical tomotherapy and intensity-modulated radiation therapy plans for non-small cell lung cancer.
Meng LL; Feng LC; Wang YL; Dai XK; Xie CB
Chin Med J (Engl); 2011 Jun; 124(11):1667-71. PubMed ID: 21740774
[TBL] [Abstract][Full Text] [Related]
48. A longitudinal evaluation of improvements in radiotherapy treatment plan quality for head and neck cancer patients.
Tol JP; Doornaert P; Witte BI; Dahele M; Slotman BJ; Verbakel WF
Radiother Oncol; 2016 May; 119(2):337-43. PubMed ID: 27130730
[TBL] [Abstract][Full Text] [Related]
49. Pancreatic cancer planning: Complex conformal vs modulated therapies.
Chapman KL; Witek ME; Chen H; Showalter TN; Bar-Ad V; Harrison AS
Med Dosim; 2016; 41(2):100-4. PubMed ID: 26831922
[TBL] [Abstract][Full Text] [Related]
50. Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy.
Huang H; Lu H; Feng G; Jiang H; Chen J; Cheng J; Pang Q; Lu Z; Gu J; Peng L; Deng S; Mo Y; Wu D; Wei Y
Radiat Oncol; 2015 Sep; 10():192. PubMed ID: 26377685
[TBL] [Abstract][Full Text] [Related]
51. Applying the technique of volume-modulated arc radiotherapy to upper esophageal carcinoma.
Ma P; Wang X; Xu Y; Dai J; Wang L
J Appl Clin Med Phys; 2014 May; 15(3):4732. PubMed ID: 24892348
[TBL] [Abstract][Full Text] [Related]
52. Using overlap volume histogram and IMRT plan data to guide and automate VMAT planning: a head-and-neck case study.
Wu B; Pang D; Simari P; Taylor R; Sanguineti G; McNutt T
Med Phys; 2013 Feb; 40(2):021714. PubMed ID: 23387737
[TBL] [Abstract][Full Text] [Related]
53. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
54. Comparison of biological-based and dose volume-based intensity-modulated radiotherapy plans generated using the same treatment planning system.
Senthilkumar K; Maria Das KJ
J Cancer Res Ther; 2019 Mar; 15(Supplement):S33-S38. PubMed ID: 30900617
[TBL] [Abstract][Full Text] [Related]
55. A dosimetric analysis of tomotherapy based intensity modulated radiation therapy with and without bone marrow sparing in gynecologic malignancies.
Platta CS; Bayliss A; McHaffie D; Tome WA; Straub MR; Bradley KA
Technol Cancer Res Treat; 2013 Feb; 12(1):19-29. PubMed ID: 22974331
[TBL] [Abstract][Full Text] [Related]
56. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
[TBL] [Abstract][Full Text] [Related]
57. Predicting dose-volume histograms for organs-at-risk in IMRT planning.
Appenzoller LM; Michalski JM; Thorstad WL; Mutic S; Moore KL
Med Phys; 2012 Dec; 39(12):7446-61. PubMed ID: 23231294
[TBL] [Abstract][Full Text] [Related]
58. Predicting objective function weights from patient anatomy in prostate IMRT treatment planning.
Lee T; Hammad M; Chan TC; Craig T; Sharpe MB
Med Phys; 2013 Dec; 40(12):121706. PubMed ID: 24320492
[TBL] [Abstract][Full Text] [Related]
59. Comprehensive Comparison of Progressive Optimization Algorithm Based Automatic Plan and Manually Planned Treatment Technique for Cervical-Thoracic Esophageal Cancers.
Zhou Y; Xiang X; Xiong J; Gong C
Technol Cancer Res Treat; 2020; 19():1533033820973283. PubMed ID: 33176589
[TBL] [Abstract][Full Text] [Related]
60. An Automated Treatment Plan Quality Control Tool for Intensity-Modulated Radiation Therapy Using a Voxel-Weighting Factor-Based Re-Optimization Algorithm.
Song T; Li N; Zarepisheh M; Li Y; Gautier Q; Zhou L; Mell L; Jiang S; Cerviño L
PLoS One; 2016; 11(3):e0149273. PubMed ID: 26930204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
